Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03216590
Other study ID # HYMC-17-0033
Secondary ID
Status Not yet recruiting
Phase N/A
First received July 9, 2017
Last updated July 12, 2017
Start date July 20, 2017
Est. completion date December 20, 2017

Study information

Verified date July 2017
Source Hillel Yaffe Medical Center
Contact Ofir Uri, MD
Phone +972-52-3863228
Email ofiruri@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Strategies to minimize soft tissue swelling during shoulder arthroscopy are constantly sought after. The investigators propose an unfamiliar method which may reduce tissue swelling during shoulder arthroscopy.


Description:

Fluid extravasation into the surrounding tissue is common in shoulder arthroscopy. It frequently leads to soft tissue swelling and edema which results in poor visualization and prolonged surgical time. While usually resolves uneventfully within 12 hours, excessive fluid extravasation into the soft tissue around the shoulder may lead to serious consequences and complications such as airway compromise, tracheal deviation, neuropraxias, habdomyoloysis and skin necrosis have been reported in the literature. Methods aimed at reducing soft tissue swelling during shoulder arthroscopy in order to avoid complications (e.g., low pump pressure, short arthroscopic time) are routinely practiced. Nevertheless, fluid extravasation and soft tissue swelling remains a concern in shoulder arthroscopy.

The purpose of the current study is to evaluate whether applying local compression to the shoulder by preoperative compressive draping will reduce soft tissue swelling during shoulder arthroscopy. To the investigators' knowledge, no previous study evaluated the influence of applying compressive draping to the shoulder on soft tissue swelling in shoulder arthroscopy.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date December 20, 2017
Est. primary completion date December 20, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria for the study are defined as:

1. Surgery indicated for chronic symptomatic RC tear unresponsive to non-operative treatment over a minimal period of 6 months.

2. Small to medium size tears (<3 cm).

3. Age older than 18 years.

4. ASA score 1or 2.

5. Body mass index (BMI) < 35.

6. Willingness to provide an informed consent.

Exclusion criteria:

1. Pregnant women.

2. Arthroscopic procedure that was converted to an open ("mini-open") surgery.

3. Patients who do not meet the above mentioned inclusion criteria.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Compressive draping using adhesive incise drape
In the intervention group the shoulder will be drape with compressive draping using adhesive incise drape (Ioban™2 Antimicrobial Incise Drape, 3M Inc.,USA).

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hillel Yaffe Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary Change on shoulder circumference The change in shoulder circumference will be assessed at the end of the procedure. Shoulder circumference before and at the end of the procedure will be measured from the mid-point between the coracoid process and anterior axillary fold anteriorly to the mid-point between the scapular spine and the posterior axillary fold posteriorly. Immediate post-operative
See also
  Status Clinical Trial Phase
Completed NCT02291185 - Prediction of Fluid Responsiveness Using Dynamic Preload Indices During Arthroscopic Shoulder Surgery in the Beach Chair Position N/A
Completed NCT02688530 - Intravenous Dexamethasone on Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy Phase 4
Unknown status NCT02178449 - Prolongation of Pain Free Time by the Use of Dexamethasone in Peripheral Nerve Blockade Phase 4
Completed NCT05244525 - Subacromial Injection of Epinephrine Improves Visualization in Shoulder Arthroscopy Phase 4
Recruiting NCT05727345 - Shoulder Anterior Capsular Block and Interscalene Brachial Plexus Block for Shoulder Arthroscopy N/A
Withdrawn NCT01112878 - Oral Clonidine & Gabapentin: Improving Recovery and Pain Management After Outpatient With Major Orthopedic Surgery Phase 4
Enrolling by invitation NCT04610164 - The Effect of Tranexamic Acid (TXA) on Visualization During Shoulder Arthroscopy Phase 3
Completed NCT02181296 - Pulmonary Function and Interscalene Block N/A
Recruiting NCT05788367 - Pericapsular Nerve Block Versus Interscalene Nerve Block for Acute Pain Management in Shoulder Arthroscopy N/A
Completed NCT01877330 - Optimal Location of Local Anesthetic Injection for Ultrasound Guided Interscalene Block N/A
Completed NCT01377415 - Continuous Subacromial Bupivacaine N/A
Completed NCT05453266 - Arthroscopic Rotator Cuff Repair Performed With Intraarticular Tranexamic Acid Could it Provide Improved Visual Clarity and Less Post-operative Pain? A Prospective, Double Blind, Randomized Study of 64 Patients. N/A
Completed NCT04566250 - Non-Opioid Prescriptions After Arthroscopic Surgery in Canada (NO PAin) N/A
Recruiting NCT06235879 - Comparison Between Pericapsular Nerve Group (PENG) Block and Interscalene Brachial Plexus Block for Postoperative Analgesia Following Shoulder Arthroscopy N/A
Completed NCT02506660 - Interscalene Block With Low-dose IV vs. Perineural Dexamethasone for Shoulder Arthroscopy Phase 4
Completed NCT01701115 - Effect of Local Anesthetic Dose on Interscalene Block N/A
Completed NCT04483323 - Erector Spinae Plane Block Versus Intraarticular Injection for Postoperative Analgesia in Shoulder Arthroscopy N/A